Zhejiang Jingxin Pharmaceutical Stock Forecast for 2023 - 2025 - 2030

Updated on 04/28/2024

Stock Rating
18
Price Target
¥6.48
Consensus
Outperform
Downside
-43.21%
Analysts
0
Stock Rating
18
Downside
-43.21%
Analysts
0
Price Target
¥6.48

Zhejiang Jingxin Pharmaceutical Stock Forecast and Price Target

According to experts, who recently provided their 2024 price targets for Zhejiang Jingxin Pharmaceutical, the average price target is ¥6.48, with a high estimate of ¥7.25 and a low estimate of ¥5.76. That is a potential downside of approximately -43.21% from the last closing price of ¥11.41 on April, 2024. Even if you are not interested in 002020 stock, it is still imperative to be aware of its competitors.

¥6.48

-43.21% Downside

Buy
Buy

Zhejiang Jingxin Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Zhejiang Jingxin Pharmaceutical's Price has decreased by 100.00%, going from ¥9.13 to ¥0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ¥12.95 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Zhejiang Jingxin Pharmaceutical will be 100.00%.

2024 Fair Value Forecast
¥12.95
2025 Fair Value Forecast
¥15.46
2026 Fair Value Forecast
¥16.49
2027 Fair Value Forecast
¥9.76
2028 Fair Value Forecast
¥11.27
2029 Fair Value Forecast
¥13.12
2030 Fair Value Forecast
¥14.93
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002001 Stock Forecast Zhejiang NHU Outperform 17
¥18.35 Buy/Sell ¥20.23 4.63%
000423 Stock Forecast Dong-E-E-Jiao Buy 14
¥66.60 Buy/Sell ¥57.05 3.08%
688363 Stock Forecast Bloomage BioTechnology Corpora... Outperform 17
¥59.92 Buy/Sell ¥97.00 30.17%
600521 Stock Forecast Zhejiang Huahai Pharmaceutical Outperform 14
¥16.05 Buy/Sell ¥19.80 -2.80%
603707 Stock Forecast Nanjing King-Friend Biochemica... Buy 16
¥13.91 Buy/Sell ¥20.19 45.15%

Zhejiang Jingxin Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Revenue for Zhejiang Jingxin Pharmaceutical has grown by 22.74%, going from ¥3.26B to ¥4.00B. 0 analysts predict Zhejiang Jingxin Pharmaceutical's Revenue will decrease by 6.59% in the next year, reaching ¥3.74B. By 2030, professionals predict that Zhejiang Jingxin Pharmaceutical's Revenue will decrease by 6.87%, to ¥3.72B.

2024 Rev Forecast
¥3.74B
2025 Rev Forecast
¥3.65B
2026 Rev Forecast
¥3.70B
2027 Rev Forecast
¥3.80B
2028 Rev Forecast
¥3.78B
2029 Rev Forecast
¥3.74B
2030 Rev Forecast
¥3.72B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000739 Stock Forecast Apeloa Pharmaceutical Co.,Ltd Buy 16
¥13.64 Buy/Sell ¥23.46 30.13%
603456 Stock Forecast Zhejiang Jiuzhou Pharmaceutica... Buy 18
¥15.60 Buy/Sell ¥37.79 51.35%
600267 Stock Forecast Zhejiang Hisun Pharmaceutical Hold 11
¥7.87 Buy/Sell ¥15.60 5.46%

Zhejiang Jingxin Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030

Zhejiang Jingxin Pharmaceutical's Dividend per Share has grown in the last three years, jumping from ¥0.29 to ¥0.30 – an increase of 3.45%. For the following year, the 1 analysts predict that Zhejiang Jingxin Pharmaceutical's Dividend per Share will drop by 100.00%, reaching ¥0.00. For the next seven years, the forecast is for Dividend per Share to grow by 33.04%.

2024 DPS Forecast
¥0.00
2025 DPS Forecast
¥0.00
2026 DPS Forecast
¥0.46
2027 DPS Forecast
¥0.61
2028 DPS Forecast
¥0.56
2029 DPS Forecast
¥0.34
2030 DPS Forecast
¥0.40
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600572 Stock Forecast Zhejiang CONBA Pharmaceutical Outperform 13
¥4.91 Buy/Sell ¥9.80 -37.68%
300705 Stock Forecast Hunan Jiudian Pharmaceutical Buy 16
¥36.22 Buy/Sell ¥36.00 -100.00%
002581 Stock Forecast Shandong Sinobioway Biomedicin... - 9
¥12.63 Buy/Sell ¥0.00 -100.00%

Zhejiang Jingxin Pharmaceutical Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002675 Stock Forecast Yantai Dongcheng Pharmaceutica... Buy 18
¥13.31 Buy/Sell ¥20.30 52.52%
603229 Stock Forecast Zhejiang Ausun Pharmaceutical Buy 14
¥10.56 Buy/Sell ¥0.00 -100.00%
002099 Stock Forecast Zhejiang Hisoar Pharmaceutical - 14
¥5.93 Buy/Sell ¥13.00 -100.00%

Zhejiang Jingxin Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Zhejiang Jingxin Pharmaceutical's EBITDA has grown, increasing from ¥637.23M to ¥778.68M – an increase of 22.20%. For next year, the 2 analysts predict EBITDA of ¥987.50M, which would mean an increase of 26.82%. Over the next seven years, the pros' prediction is EBITDAof ¥1.41B, which would mean a seven-year growth forecast of 81.11%.

2024 EBITDA Forecast
¥0.99B
2025 EBITDA Forecast
¥1.16B
2026 EBITDA Forecast
¥1.72B
2027 EBITDA Forecast
¥1.33B
2028 EBITDA Forecast
¥1.25B
2029 EBITDA Forecast
¥1.26B
2030 EBITDA Forecast
¥1.41B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300363 Stock Forecast Porton Pharma Solutions Outperform 18
¥16.98 Buy/Sell ¥37.00 67.84%
000597 Stock Forecast Northeast Pharmaceutical Group - 16
¥4.89 Buy/Sell ¥0.00 -100.00%
300702 Stock Forecast Zhejiang Tianyu Pharmaceutical Buy 16
¥18.11 Buy/Sell ¥26.00 43.57%

Zhejiang Jingxin Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030

Zhejiang Jingxin Pharmaceutical's EBIT has increased by 11.51% In the last three years, going from ¥519.31M to ¥579.08M. In the next year, analysts expect EBIT to reach ¥862.00M – an increase of 48.86%. For the next seven years, the forecast is for EBIT to grow by 73.30%.

2024 EBIT Forecast
¥0.86B
2025 EBIT Forecast
¥1.03B
2026 EBIT Forecast
¥1.10B
2027 EBIT Forecast
¥0.90B
2028 EBIT Forecast
¥0.90B
2029 EBIT Forecast
¥0.95B
2030 EBIT Forecast
¥1.00B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600713 Stock Forecast NanJing Pharmaceutical Company - 16
¥4.74 Buy/Sell ¥11.60 -100.00%
300109 Stock Forecast Boai NKY Medical Holdings - 18
¥16.58 Buy/Sell ¥0.00 -100.00%
300497 Stock Forecast Jiangxi Fushine Pharmaceutical - 15
¥8.48 Buy/Sell ¥0.00 -100.00%

Zhejiang Jingxin Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Zhejiang Jingxin Pharmaceutical's EPS has decreased by 100.00%, going from ¥0.62 to ¥0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ¥0.88 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Zhejiang Jingxin Pharmaceutical will be 100.00%.

2024 EPS Forecast
¥0.88
2025 EPS Forecast
¥1.05
2026 EPS Forecast
¥1.12
2027 EPS Forecast
¥0.66
2028 EPS Forecast
¥0.77
2029 EPS Forecast
¥0.89
2030 EPS Forecast
¥1.01
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300261 Stock Forecast ABA Chemicals - 18
¥5.86 Buy/Sell ¥7.00 -100.00%
000566 Stock Forecast Hainan Haiyao - 8
¥3.50 Buy/Sell ¥14.50 -100.00%
600466 Stock Forecast Sichuan Languang Development - 16
¥0.40 Buy/Sell ¥6.89 -100.00%